{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:40:17Z","timestamp":1783521617279,"version":"3.55.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.arr.2024.102615","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T07:34:08Z","timestamp":1733124848000},"page":"102615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["An overview on the impact of viral pathogens on Alzheimer's disease"],"prefix":"10.1016","volume":"104","author":[{"given":"Melika","family":"AmeliMojarad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"AmeliMojarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102615_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/genes10030222","article-title":"The genetic variability of APOE in different human populations and its implications for longevity","volume":"10","author":"Abondio","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.arr.2024.102615_bib2","doi-asserted-by":"crossref","first-page":"1000205","DOI":"10.1371\/journal.ppat.1000205","article-title":"Alteration of blood\u2013brain barrier integrity by retroviral infection","volume":"4","author":"Afonso","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.arr.2024.102615_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/14787210.2014.887442","article-title":"How plausible is a link between HSV-1 infection and Alzheimer\u2019s disease?","volume":"12","author":"Agostini","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.arr.2024.102615_bib4","article-title":"The repurposed ACE2 inhibitors: SARS-CoV-2 entry blockers of Covid-19","volume":"379","author":"Ahmad","year":"2021","journal-title":"Top. Curr. Chem. (Cham)"},{"key":"10.1016\/j.arr.2024.102615_bib5","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/ene.14442","article-title":"Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system","volume":"27","author":"Alam","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2024.102615_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.33594\/000000590","article-title":"Simvastatin therapy increased miR-150-5p expression in the patients with type 2 diabetes and COVID-19","volume":"56","author":"AmeliMojarad","year":"2022","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.arr.2024.102615_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2445","article-title":"Interleukin-6 inhibitory effect of natural product naringenin compared to a synthesised monoclonal antibody against life-threatening COVID-19","volume":"33","author":"AmeliMojarad","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.arr.2024.102615_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jnr.10762","article-title":"HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells","volume":"74","author":"Andr\u00e1s","year":"2003","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.arr.2024.102615_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701282","article-title":"Activation of NLRP3 inflammasome and onset of Alzheimer\u2019s disease","volume":"12","author":"Bai","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2024.102615_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview","volume":"16","author":"Ballabh","year":"2004","journal-title":"Struct., Regul., Clin. Implic. Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102615_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222505","article-title":"Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer\u2019s disease mortality","volume":"14","author":"Benito-Le\u00f3n","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102615_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.arr.2024.102615_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer\u2019s disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102615_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3233\/ADR-220061","article-title":"Interaction mechanism between the HSV-1 glycoprotein B and the antimicrobial peptide amyloid-\u03b2","volume":"6","author":"Bourgade","year":"2022","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.arr.2024.102615_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102615_bib16","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1073\/pnas.0803526105","article-title":"Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE \u03b54\/\u03b54 genotype accelerates HIV disease progression","volume":"105","author":"Burt","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2024.102615_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105131","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier","volume":"146","author":"Buzhdygan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2024.102615_bib18","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-180098","article-title":"Role of blood-brain barrier in Alzheimer\u2019s disease","volume":"63","author":"Cai","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.arr.2024.102615_bib19","first-page":"1","article-title":"The COVID-19 pandemic and Alzheimer\u2019s disease: mutual risks and mechanisms","volume":"11","author":"Chen","year":"2022","journal-title":"Transl. Neurodegener. 2022"},{"key":"10.1016\/j.arr.2024.102615_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.omtn.2023.07.031","article-title":"Apolipoprotein E and viral infection: risks and mechanisms","volume":"33","author":"Chen","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.arr.2024.102615_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.omtn.2023.07.031","article-title":"Apolipoprotein E and viral infection: risks and mechanisms","volume":"33","author":"Chen","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"9","key":"10.1016\/j.arr.2024.102615_bib22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin. 2017"},{"key":"10.1016\/j.arr.2024.102615_bib23","article-title":"The dual role of low-density lipoprotein receptor-related protein 1 in atherosclerosis","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.arr.2024.102615_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02579-8","article-title":"COVID-19 and cognitive impairment: neuroinvasive and blood-brain barrier dysfunction","volume":"19","author":"Chen","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2024.102615_bib25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102615_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102615_bib27","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0002-9440(10)65511-3","article-title":"Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis","volume":"155","author":"Dallasta","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2024.102615_bib28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102615_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/ajh\/hpab085","article-title":"COVID-19 and ROS storm: what is the forecast for hypertension","volume":"34","author":"De Oliveira","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.arr.2024.102615_bib30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid \u03b2\u2013mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.arr.2024.102615_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11910-018-0863-1","article-title":"Viral hypothesis and antiviral treatment in Alzheimer\u2019s disease","volume":"18","author":"Devanand","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.arr.2024.102615_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032112","article-title":"Antiviral therapy: valacyclovir treatment of Alzheimer\u2019s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial","volume":"10","author":"Devanand","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2024.102615_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032112","article-title":"Antiviral therapy: Valacyclovir Treatment of Alzheimer\u2019s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial","volume":"10","author":"Devanand","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2024.102615_bib34","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","article-title":"CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood\u2013brain barrier: a potential mechanism of HIV\u2013CNS invasion and NeuroAIDS","volume":"26","author":"Eugenin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102615_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000255051","article-title":"Increased serum IL-1\u03b2 Level in Alzheimer\u2019s disease and mild cognitive impairment","volume":"28","author":"Forlenza","year":"2010","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2024.102615_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/187152711794653751","article-title":"Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases","volume":"10","author":"Frankola","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"9","key":"10.1016\/j.arr.2024.102615_bib37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41589-022-01059-7","article-title":"Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation","volume":"18","author":"Fraser","year":"2022","journal-title":"Nat. Chem. Biol. 2022"},{"key":"10.1016\/j.arr.2024.102615_bib38","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/ncomms3030","article-title":"Scara1 deficiency impairs clearance of soluble Amyloid-\u03b2 by mononuclear phagocytes and accelerates Alzheimer\u2019s-like disease progression","volume":"4","author":"Frenkel","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2024.102615_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/j.1875-9114.1983.tb03274.x","article-title":"Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications","volume":"3","author":"Gnann","year":"1983","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.arr.2024.102615_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","article-title":"\u03b2-Amyloid peptides and amyloid plaques in Alzheimer\u2019s disease","volume":"12","author":"Gouras","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2024.102615_bib41","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1128\/JVI.00954-09","article-title":"Mouse adenovirus type 1-induced breakdown of the blood-brain barrier","volume":"83","author":"Gralinski","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.arr.2024.102615_bib42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102615_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/2633105520975743","article-title":"The intersection between COVID-19, the gene family of ACE2 and Alzheimer\u2019s disease","volume":"15","author":"Haghighi","year":"2020","journal-title":"Neurosci. Insights"},{"key":"10.1016\/j.arr.2024.102615_bib44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.arr.2024.102615_bib45","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1128\/AAC.36.9.1890","article-title":"Mechanism of action of the antiherpesvirus biflavone ginkgetin","volume":"36","author":"Hayashi","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.arr.2024.102615_bib46","unstructured":"How Biogen\u2019s Aduhelm Approval Marks a Precipitous Turning Point for the FDA [WWW Document], n.d. URL \u3008https:\/\/www.ajmc.com\/view\/how-biogen-s-aduhelm-approval-marks-a-precipitous-turning-point-for-the-fda\u3009 (accessed 10.22.24)."},{"key":"10.1016\/j.arr.2024.102615_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158226","article-title":"The effects of A\u03b21-42 binding to the SARS-CoV-2 spike protein S1 subunit and angiotensin-converting enzyme 2","volume":"22","author":"Hsu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102615_bib48","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1523\/JNEUROSCI.2994-18.2019","article-title":"Differential signaling mediated by ApoE2, ApoE3, and ApoE4 in human neurons parallels Alzheimer\u2019s disease risk","volume":"39","author":"Huang","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2024.102615_bib49","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s00213-020-05503-1","article-title":"The combination of acyclovir and dexamethasone protects against Alzheimer\u2019s disease-related cognitive impairments in mice","volume":"237","author":"Hui","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.arr.2024.102615_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21144920","article-title":"The use of antimicrobial and antiviral drugs in Alzheimer\u2019s disease","volume":"21","author":"Iqbal","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102615_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00202","article-title":"Herpes simplex virus type 1 and Alzheimer\u2019s disease: increasing evidence for a major role of the virus","volume":"6","author":"Itzhaki","year":"2014","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102615_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00202","article-title":"Herpes simplex virus type 1 and Alzheimer\u2019s disease: increasing evidence for a major role of the virus","volume":"6","author":"Itzhaki","year":"2014","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102615_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnagi.2018.00324","article-title":"Corroboration of a major role for herpes simplex virus type 1 in Alzheimer\u2019s disease","volume":"10","author":"Itzhaki","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102615_bib54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","article-title":"Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease","volume":"349","author":"Itzhaki","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102615_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01055-22","article-title":"Membrane-tethered mucin 1 is stimulated by interferon and virus infection in multiple cell types and inhibits influenza A virus infection in human airway epithelium","volume":"13","author":"Iverson","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.arr.2024.102615_bib56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/13550280902998413","article-title":"Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization","volume":"15","author":"Ivey","year":"2009","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.arr.2024.102615_bib57","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS 2020"},{"key":"10.1016\/j.arr.2024.102615_bib58","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11481-010-9208-9","article-title":"Microbial induction of vascular pathology in the CNS","volume":"5","author":"Kang","year":"2010","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.arr.2024.102615_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-\u03b2 and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102615_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102615_bib61","article-title":"COVID-19 and long COVID: disruption of the neurovascular unit, blood-brain barrier, and tight junctions","author":"Kempuraj","year":"2023","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.arr.2024.102615_bib62","first-page":"392","article-title":"New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease","volume":"8","author":"Kleymann","year":"2002","journal-title":"Nat. Med. 2002"},{"key":"10.1016\/j.arr.2024.102615_bib63","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/gerona\/glaa169","article-title":"ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank","volume":"75","author":"Kuo","year":"2020","journal-title":"J. Gerontol.: Ser. A"},{"issue":"1","key":"10.1016\/j.arr.2024.102615_bib64","article-title":"Zika virus infection accelerates Alzheimer\u2019s disease phenotypes in brain organoids","volume":"8","author":"Lee","year":"2022","journal-title":"Cell Death Discov. 2022"},{"key":"10.1016\/j.arr.2024.102615_bib65","article-title":"Alzheimer\u2019s disease and COVID-19: Interactions, intrinsic linkages, and the role of immunoinflammatory responses in this process","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2024.102615_bib66","article-title":"The Role of NLRP3 inflammasome in Alzheimer\u2019s disease and potential therapeutic targets","volume":"13","author":"Liang","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.arr.2024.102615_bib67","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102615_bib68","doi-asserted-by":"crossref","unstructured":"Long, J.M., Holtzman, D.M., n.d. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339. https:\/\/doi.org\/10.1016\/J.CELL.2019.09.001.","DOI":"10.1016\/j.cell.2019.09.001"},{"key":"10.1016\/j.arr.2024.102615_bib69","article-title":"Herpesvirus infections, antiviral treatment, and the risk of dementia\u2014a registry-based cohort study in Sweden","volume":"7","author":"Lopatko Lindman","year":"2021","journal-title":"Alzheimer\u2019s Dement.: Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2024.102615_bib70","article-title":"Herpesvirus infections, antiviral treatment, and the risk of dementia\u2014a registry-based cohort study in Sweden","volume":"7","author":"Lopatko Lindman","year":"2021","journal-title":"Alzheimer\u2019s Dement.: Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2024.102615_bib71","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.arr.2024.102615_bib72","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1042\/CS20200899","article-title":"ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV","volume":"134","author":"Lubbe","year":"2020","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.arr.2024.102615_bib73","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1042\/CS20200899","article-title":"ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV","volume":"134","author":"Lubbe","year":"2020","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.arr.2024.102615_bib74","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14787210.2019.1656064","article-title":"Herpes simplex virus type 1 and Alzheimer\u2019s disease: link and potential impact on treatment","volume":"17","author":"Mancuso","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.arr.2024.102615_bib75","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102615_bib76","unstructured":"Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer\u2019s disease: International Journal of Neuroscience: Vol 124, No 5 [WWW Document], n.d."},{"key":"10.1016\/j.arr.2024.102615_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101729","article-title":"Exploring the role of COX-2 in Alzheimer\u2019s disease: potential therapeutic implications of COX-2 inhibitors","volume":"31","author":"Moussa","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.arr.2024.102615_bib78","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer\u2019s disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102615_bib79","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the \u03b2-amyloid peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"7691","key":"10.1016\/j.arr.2024.102615_bib80","first-page":"249","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature 2018"},{"key":"10.1016\/j.arr.2024.102615_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"Neurath","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.arr.2024.102615_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","author":"Orihuela","year":"2016","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.arr.2024.102615_bib83","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41586-022-05344-2","article-title":"Common human genetic variants of APOE impact murine COVID-19 mortality","volume":"611","author":"Ostendorf","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102615_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-6-45","article-title":"Microglial phagocytosis induced by fibrillar \u03b2-amyloid is attenuated by oligomeric \u03b2-amyloid: implications for Alzheimer\u2019s disease","volume":"6","author":"Pan","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102615_bib85","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/microorganisms8070972","article-title":"Multiple herpes simplex virus-1 (HSV-1) reactivations induce protein oxidative damage in mouse brain: novel mechanisms for Alzheimer\u2019s disease progression","volume":"8","author":"Protto","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.arr.2024.102615_bib86","article-title":"Low-density lipoprotein receptor-related protein 1 (LRP1) is a novel receptor for apolipoprotein A4 (APOA4) in adipose tissue","volume":"11","author":"Qu","year":"2021","journal-title":"Sci. Rep. 2021"},{"key":"10.1016\/j.arr.2024.102615_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007427","article-title":"Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer\u2019s disease","volume":"14","author":"Rathore","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.arr.2024.102615_bib88","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins","volume":"13","author":"Ray","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102615_bib89","first-page":"240","article-title":"Viral infections, are they a trigger and risk factor of Alzheimer\u2019s disease?","volume":"13","author":"Rippee-Brooks","year":"2024","journal-title":"Pathogens 2024"},{"key":"10.1016\/j.arr.2024.102615_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20032146","article-title":"Links between COVID-19 and Alzheimer\u2019s disease\u2014what do we already know?","volume":"20","author":"Rudnicka-Dro\u017cak","year":"2023","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.arr.2024.102615_bib91","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainres.2006.09.093","article-title":"Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation","volume":"1125","author":"Sellner","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2024.102615_bib92","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102615_bib93","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The infectious etiology of Alzheimer\u2019s disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102615_bib94","article-title":"The Pivotal Role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease","volume":"23","author":"Sun","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102615_bib95","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2018.02.015","article-title":"Neuroinflammation in Alzheimer\u2019s disease: pleiotropic roles for cytokines and neuronal pentraxins","volume":"347","author":"Swanson","year":"2018","journal-title":"Behav. brain Res."},{"key":"10.1016\/j.arr.2024.102615_bib96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102615_bib97","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(00)00404-5","article-title":"IL-4, IL-10 and IL-13 modulate A\u03b2(1\u201342)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line","volume":"113","author":"Szczepanik","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.arr.2024.102615_bib98","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3597","article-title":"Association of chronic low-grade inflammation with risk of Alzheimer disease in ApoE4 carriers","volume":"1","author":"Tao","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.arr.2024.102615_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-06932-3","article-title":"ApoE influences the blood-brain barrier through the NF-\u03baB\/MMP-9 pathway after traumatic brain injury","volume":"7","author":"Teng","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102615_bib100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2011.02.004","article-title":"2011 Alzheimer\u2019s disease facts and figures","volume":"7","author":"Thies","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102615_bib101","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2024.102615_bib102","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1097\/00002030-199912030-00005","article-title":"Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice","volume":"13","author":"Toneatto","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.arr.2024.102615_bib103","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1476-5381.2010.00982.x","article-title":"Japanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF-\u03baB signalling dependent on MAPKs and reactive oxygen species","volume":"161","author":"Tung","year":"2010","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.arr.2024.102615_bib104","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/CIA.S325026","article-title":"Role of aducanumab in the treatment of Alzheimer\u2019s disease: challenges and opportunities","volume":"17","author":"Vaz","year":"2022","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.arr.2024.102615_bib105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2008.11.047","article-title":"West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier","volume":"385","author":"Verma","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.arr.2024.102615_bib106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.virol.2009.10.036","article-title":"Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor","volume":"397","author":"Verma","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.arr.2024.102615_bib107","unstructured":"Viral role in Alzheimer\u2019s Disease discovered | University of Oxford [WWW Document], n.d. URL \u3008https:\/\/www.ox.ac.uk\/news\/2022-08-02-viral-role-alzheimers-disease-discovered\u3009 (accessed 10.21.24)."},{"key":"10.1016\/j.arr.2024.102615_bib108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-385883-2.00012-6","article-title":"Alzheimer\u2019s disease and the amyloid \u03b2-protein","volume":"107","author":"Walsh","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.arr.2024.102615_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00818-7","article-title":"Neurological complications and infection mechanism of SARS-COV-2","volume":"6","author":"Wan","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2024.102615_bib110","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0911-0","article-title":"EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.arr.2024.102615_bib111","doi-asserted-by":"crossref","first-page":"31831","DOI":"10.1074\/jbc.M303592200","article-title":"Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity","volume":"278","author":"Weggen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102615_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030525","article-title":"CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer\u2019s disease","volume":"7","author":"Westin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102615_bib113","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/ajh\/hpaa217","article-title":"A Cytokine\/Bradykinin Storm Comparison: What Is the Relationship between Hypertension and COVID-19?","volume":"34","author":"Wilczynski","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.arr.2024.102615_bib114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/ijms20010081","article-title":"The Role of APOE and TREM2 in Alzheimer\u2032s disease\u2014current understanding and Perspectives","volume":"20","author":"Wolfe","year":"2018","journal-title":"Int. J. Mol. Sci. 2019"},{"key":"10.1016\/j.arr.2024.102615_bib115","first-page":"706","article-title":"Alzheimer disease: ApoE4 implicated in tau-mediated neurodegeneration","volume":"13","author":"Wood","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102615_bib116","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2009-0963","article-title":"Alzheimer\u2019s disease-specific tau phosphorylation is induced by herpes simplex virus type 1","volume":"16","author":"Wozniak","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102615_bib117","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2009-0963","article-title":"Alzheimer\u2019s disease-specific tau phosphorylation is induced by herpes simplex virus type 1","volume":"16","author":"Wozniak","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102615_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025152","article-title":"Antivirals reduce the formation of key Alzheimer\u2019s disease molecules in cell cultures acutely infected with herpes simplex virus type 1","volume":"6","author":"Wozniak","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2024.102615_bib119","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.antiviral.2013.07.003","article-title":"The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer\u2019s disease-related molecules induced by herpes simplex virus type 1","volume":"99","author":"Wozniak","year":"2013","journal-title":"Antivir. Res"},{"key":"10.1016\/j.arr.2024.102615_bib120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-021-00237-2","article-title":"COVID-19 and Alzheimer\u2019s disease: how one crisis worsens the other","volume":"10","author":"Xia","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102615_bib121","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-021-00237-2","article-title":"COVID-19 and Alzheimer\u2019s disease: how one crisis worsens the other","volume":"10","author":"Xia","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102615_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114724","article-title":"Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)","volume":"192","author":"Xiang","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.arr.2024.102615_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2011.11.052","article-title":"HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9","volume":"1436","author":"Xu","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2024.102615_bib124","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ije\/dyaa241","article-title":"Systemic inflammatory regulators and risk of Alzheimer\u2019s disease: a bidirectional Mendelian-randomization study","volume":"50","author":"Yeung","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.arr.2024.102615_bib125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2017.03.021","article-title":"Immune hyperreactivity of A\u03b2 plaque-associated microglia in Alzheimer\u2019s disease","volume":"55","author":"Yin","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102615_bib126","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-2008-14301","article-title":"Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1","volume":"14","author":"Zambrano","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102615_bib127","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Med. (Kaunas. )"},{"key":"10.1016\/j.arr.2024.102615_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.749587","article-title":"Microglia in Alzheimer\u2019s disease: a target for therapeutic intervention","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.arr.2024.102615_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01118-4","article-title":"APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2024.102615_bib130","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/15548627.2022.2099206","article-title":"Neutrophil autophagy and NETosis in COVID-19: perspectives","volume":"19","author":"Zhang","year":"2023","journal-title":"Autophagy"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724004331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724004331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T16:55:55Z","timestamp":1738860955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724004331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":130,"alternative-id":["S1568163724004331"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102615","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview on the impact of viral pathogens on Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102615"}}